한글목차

관상동맥 스텐트 시장 규모는 최근 현저하게 확대하고 있습니다. 2025년 119억 달러에서 2026년에는 129억 달러로, CAGR 8.3%로 성장이 전망되고 있습니다. 지난 수년간 관상동맥질환 유병률 증가, 경피적 관상동맥중재술(PCI) 시술 건수 증가, 스텐트 코팅 기술 발전, 중재적 심장병학 서비스 확대, 관상동맥 스텐트 삽입술의 임상적 결과 개선 등이 성장의 원인으로 꼽힙니다.

관상동맥 스텐트 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 177억 6,000만 달러에 달하며, CAGR은 8.3%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 심혈관 위험이 높은 고령화 인구 증가, 저침습적 심장 치료에 대한 수요 증가, 차세대 스텐트 기술 채택 확대, 장기적인 혈관 치료 및 환자 결과에 대한 관심 증가, 신흥 시장에서의 심장 치료 접근성 확대 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 약제용출형 스텐트 및 듀얼 테라피 스텐트 도입 증가, 최소 침습적 관상동맥 중재술에 대한 선호도 증가, 재협착 및 혈전증 위험 감소에 대한 관심 확대, 생흡수성 및 생분해성 스텐트 사용 확대, 첨단 스텐트 재료 및 디자인에 대한 수요 증가 등이 있습니다. 수요 증가를 들 수 있습니다.

심혈관 질환(CVD)의 유병률 증가는 관상동맥 스텐트 시장 확대를 견인할 것으로 예측됩니다. CVD에는 관상동맥질환, 심부전, 뇌졸중, 고혈압 등 다양한 심장 및 혈관 질환이 포함됩니다. 심혈관 질환 증가는 고령화, 비만, 당뇨, 운동부족, 불건강한 식습관, 스트레스 등 위험요인 증가 등이 원인으로 지목되고 있습니다. 관상동맥 스텐트는 좁아지거나 막힌 관상동맥을 열어 심장으로의 혈류를 개선하고 심근경색의 위험을 감소시키기 때문에 CVD 치료에 있으며, 매우 중요합니다. 예를 들어 미국 질병예방통제센터(CDC)의 발표에 따르면 2023년에는 심혈관 질환으로 인해 91만 9,032명이 사망할 것으로 예상되며, 이는 전체 사망자 중 약 3명 중 1명이 심혈관 질환으로 사망할 것으로 예측됩니다. 이러한 CVD 증가 추세는 관상동맥 스텐트 수요를 견인하고 있습니다.

관상동맥 스텐트 시장의 기업은 기존 베어메탈 스텐트 대비 재수술의 필요성을 최소화하는 약물용출 스텐트 등 첨단 제품 개발에 주력하고 있습니다. 약물용출 스텐트는 동맥의 재협착을 방지하기 위해 약물을 서서히 방출하는 약물을 코팅한 특수한 장치입니다. 예를 들어 2024년 5월, 미국에 본사를 둔 헬스케어 기업 Abbott는 인도에서 XIENCE Sierra Everolimus Eluting Coronary Stent System(XIENCE Sierra Everolimus Eluting Coronary Stent System)을 발표했습니다. 발표했습니다. 이 스텐트는 개선된 디자인, 새로운 전달 시스템, 복잡한 케이스에 맞는 고유한 사이즈 옵션이 특징입니다. 다른 XIENCE 스텐트와 마찬가지로 동맥 재폐색 위험을 감소시키는 특수 코팅이 적용되어 있으며, 12만 명 이상의 환자를 대상으로 한 120여 건의 임상시험을 통해 입증된 높은 안전성을 자랑합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Coronary stents are small, expandable tubes used to open narrowed or blocked coronary arteries, which supply blood to the heart muscle. Typically constructed from metal mesh, these devices are inserted during a procedure known as percutaneous coronary intervention (PCI) or angioplasty. The stent is delivered via a balloon catheter and expanded at the blockage site to restore proper blood flow.

The main types of coronary stents include dual therapy stents, radioactive stents, thrombectomy stents, covered stents, bioresorbable stents, biodegradable stents, hybrid stents, drug-eluting stents, and bare metal stents. Dual therapy stents integrate drug-eluting and bioresorbable technologies to offer both medication release and gradual absorption of the stent structure. Various technologies used in their manufacture include laser cutting, 3D printing, microfabrication, nanotechnology, and electropolishing. Materials used in stent production can include cobalt-chromium, stainless steel, platinum-chromium, and nickel-titanium. Stents can be self-expandable or balloon-expandable and are utilized by hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

Tariffs are impacting the coronary stents market by increasing costs for imported raw materials such as cobalt-chromium alloys, polymers, and precision manufacturing components used in advanced stent production. These cost pressures have particularly affected drug-eluting, bioresorbable, and hybrid stent segments, with asia-pacific and europe being more exposed due to global manufacturing dependencies. Increased tariffs have raised procurement costs for hospitals and ambulatory surgical centers. However, tariffs have also encouraged localized manufacturing, material innovation, and regional supply chain diversification, supporting long-term market resilience.

The coronary stents market research report is one of a series of new reports from The Business Research Company that provides coronary stents market statistics, including coronary stents industry global market size, regional shares, competitors with a coronary stents market share, detailed coronary stents market segments, market trends and opportunities, and any further data you may need to thrive in the coronary stents industry. This coronary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary stents market size has grown strongly in recent years. It will grow from $11.9 billion in 2025 to $12.9 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising prevalence of coronary artery disease, increasing number of percutaneous coronary intervention procedures, advancements in stent coating technologies, expansion of interventional cardiology services, improved clinical outcomes of coronary stenting.

The coronary stents market size is expected to see strong growth in the next few years. It will grow to $17.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to aging population with higher cardiovascular risk, increasing demand for minimally invasive cardiac treatments, growing adoption of next-generation stent technologies, rising focus on long-term vessel healing and patient outcomes, expanding access to cardiac care in emerging markets. Major trends in the forecast period include rising adoption of drug-eluting and dual therapy stents, increasing preference for minimally invasive coronary interventions, growing focus on reducing restenosis and thrombosis risks, expansion of bioresorbable and biodegradable stent usage, increasing demand for advanced stent materials and designs.

The growing prevalence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market. CVDs encompass a range of heart and blood vessel disorders, including coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population, increased rates of risk factors such as obesity, diabetes, sedentary lifestyles, poor diet, and stress. Coronary stents are crucial in treating CVDs as they help open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, representing approximately one in every three deaths. This rising prevalence of CVDs is driving the demand for coronary stents.

Companies in the coronary stent market are focusing on developing advanced products such as drug-eluting stents to minimize the need for repeat procedures compared to traditional bare-metal stents. Drug-eluting stents are specialized devices coated with medication that gradually releases drugs to prevent the re-narrowing of arteries. For instance, in May 2024, Abbott, a US-based healthcare company, introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features an enhanced design, a new delivery system, and unique size options tailored for complex cases. It maintains a specialized coating to reduce the risk of artery re-blockage, consistent with other XIENCE stents, and boasts a strong safety record supported by over 120 clinical trials involving more than 120,000 patients.

In November 2023, OrbusNeich Medical Group Holdings Limited, a China-based medical device company, acquired Eucatech AG for an undisclosed amount. Through this acquisition, OrbusNeich seeks to expand its cardiovascular product portfolio, strengthen its position in the global angioplasty and stent markets, accelerate innovation in vascular intervention solutions, and enhance its commercial presence across Europe and other key regions. Eucatech AG is a Germany-based medical device company that provides coronary stents.

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys

North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The coronary stent market consists of revenues earned by entities by providing services such as product training and education, technical support, clinical support, research and development, customized solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary stent market also includes sales of covered stents, balloon catheters, guidewires, embolic protection devices and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Stents Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses coronary stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coronary stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coronary stents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Dual Therapy Stents; Radioactive Stents; Thrombectomy Stents; Covered Stents; Bioresorbable Stents; Biodegradable Stents; Hybrid Stents; Drug-Eluting Stents; Bare Metal Stents
• 2) By Technology: Laser Cutting; 3D-Printed Stents; Microfabrication; Nanotechnology-Based Stents; Electropolishing; Others Technologies
• 3) By Raw Material: Cobalt-Chromium; Stainless Steel; Platinum-Chromium; Nickel-Titanium; Polymer
• 4) By Deployment: Self-Expandable Stents; Balloon-Expandable Stents
• 5) By End Uses: Hospitals And Ambulatory Surgical Centers; Specialty Clinics; Other End Uses
• Subsegments:
• 1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents; Paclitaxel-Eluting Dual Therapy Stents; Everolimus-Eluting Dual Therapy Stents
• 2) By Radioactive Stents: Beta Radiation Stents; Gamma Radiation Stents; Other Radiation Stents
• 3) By Thrombectomy Stents: Manual Thrombectomy Stents; Mechanical Thrombectomy Stents; Hydrodynamic Thrombectomy Stents
• 4) By Covered Stents: PTFE-Covered Stents; ePTFE-Covered Stents; Polyurethane-Covered Stents; Other Covered Stents
• 5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents; Metal-Based Bioresorbable Stents; Ceramic-Based Bioresorbable Stents
• 6) By Biodegradable Stents: Polymeric Biodegradable Stents; Magnesium-Based Biodegradable Stents; Other Biodegradable Stents
• 7) By Hybrid Stents: Hybrid Drug-Eluting Stents; Hybrid Biodegradable Or Metal Stents; Other Hybrid Stents
• 8) By Drug-Eluting Stents: Sirolimus-Eluting Stents; Paclitaxel-Eluting Stents; Everolimus-Eluting Stents; Zotarolimus-Eluting Stents; Other Drug-Eluting Stents
• 9) By Bare Metal Stents: Stainless Steel Bare Metal Stents; Cobalt Chromium Bare Metal Stents; Other Bare Metal Stents
• Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Terumo Corporation; BIOTRONIK SE & Co KG; B Braun Melsungen AG; Biosensors International Group Ltd; MicroPort Scientific Corporation; Lepu Medical Technology Beijing Co Ltd; Meril Life Sciences Pvt Ltd; Stentys SA; Alvimedica; Vascular Concepts; Balton Medical; Cardionovum; HEXACATH; Elixir Medical Corporation; Translumina GmbH; Relisys Medical Devices Ltd; REVA Medical Inc; Sahajanand Medical Technologies Pvt Ltd; Endocor GmbH; Eurocor Tech; Medinol; Q3 Medical Devices; S3V Vascular Technologies; InSitu Technologies; Minvasys
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Coronary Stents Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Coronary Stents Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Coronary Stents Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Coronary Stents Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Drug-Eluting And Dual Therapy Stents
  • 4.2.2 Increasing Preference For Minimally Invasive Coronary Interventions
  • 4.2.3 Growing Focus On Reducing Restenosis And Thrombosis Risks
  • 4.2.4 Expansion Of Bioresorbable And Biodegradable Stent Usage
  • 4.2.5 Increasing Demand For Advanced Stent Materials And Designs

5. Coronary Stents Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Ambulatory Surgical Centers
• 5.3 Specialty Cardiology Clinics
• 5.4 Cardiac Catheterization Laboratories
• 5.5 Interventional Cardiology Centers

6. Coronary Stents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Coronary Stents Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Coronary Stents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Coronary Stents Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Coronary Stents Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Coronary Stents Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Coronary Stents Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Coronary Stents Market Segmentation

• 9.1. Global Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
• 9.2. Global Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Other Technologies
• 9.3. Global Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cobalt-Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer
• 9.4. Global Coronary Stents Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Self-Expandable Stents, Balloon-Expandable Stents
• 9.5. Global Coronary Stents Market, Segmentation By End Uses, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
• 9.6. Global Coronary Stents Market, Sub-Segmentation Of Dual Therapy Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents
• 9.7. Global Coronary Stents Market, Sub-Segmentation Of Radioactive Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents
• 9.8. Global Coronary Stents Market, Sub-Segmentation Of Thrombectomy Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents
• 9.9. Global Coronary Stents Market, Sub-Segmentation Of Covered Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents
• 9.10. Global Coronary Stents Market, Sub-Segmentation Of Bioresorbable Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents
• 9.11. Global Coronary Stents Market, Sub-Segmentation Of Biodegradable Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents
• 9.12. Global Coronary Stents Market, Sub-Segmentation Of Hybrid Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents
• 9.13. Global Coronary Stents Market, Sub-Segmentation Of Drug-Eluting Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents
• 9.14. Global Coronary Stents Market, Sub-Segmentation Of Bare Metal Stents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

10. Coronary Stents Market Regional And Country Analysis

• 10.1. Global Coronary Stents Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Coronary Stents Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Coronary Stents Market

• 11.1. Asia-Pacific Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Coronary Stents Market

• 12.1. China Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Coronary Stents Market

• 13.1. India Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Coronary Stents Market

• 14.1. Japan Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Coronary Stents Market

• 15.1. Australia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Coronary Stents Market

• 16.1. Indonesia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Coronary Stents Market

• 17.1. South Korea Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Coronary Stents Market

• 18.1. Taiwan Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Coronary Stents Market

• 19.1. South East Asia Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Coronary Stents Market

• 20.1. Western Europe Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Coronary Stents Market

• 21.1. UK Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Coronary Stents Market

• 22.1. Germany Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Coronary Stents Market

• 23.1. France Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Coronary Stents Market

• 24.1. Italy Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Coronary Stents Market

• 25.1. Spain Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Coronary Stents Market

• 26.1. Eastern Europe Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Coronary Stents Market

• 27.1. Russia Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Coronary Stents Market

• 28.1. North America Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Coronary Stents Market

• 29.1. USA Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Coronary Stents Market

• 30.1. Canada Coronary Stents Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Coronary Stents Market

• 31.1. South America Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Coronary Stents Market

• 32.1. Brazil Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Coronary Stents Market

• 33.1. Middle East Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Coronary Stents Market

• 34.1. Africa Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Coronary Stents Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Coronary Stents Market Regulatory and Investment Landscape

36. Coronary Stents Market Competitive Landscape And Company Profiles

• 36.1. Coronary Stents Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Coronary Stents Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Coronary Stents Market Company Profiles
  • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. BIOTRONIK SE & Co KG Overview, Products and Services, Strategy and Financial Analysis

37. Coronary Stents Market Other Major And Innovative Companies

• B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc

38. Global Coronary Stents Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Coronary Stents Market

40. Coronary Stents Market High Potential Countries, Segments and Strategies

• 40.1 Coronary Stents Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Coronary Stents Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Coronary Stents Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer